DoubleWing Health & Beauty is a marketing and distribution company that focuses on selling foreign manufactured cosmeceutical products to Chinese consumers via its omni-channel marketplace. By an exclusive license with the established but innovative Italian brand Specchiasol we currently market certified and natural European products successfully throughout China.
Our management teams in the UK and China collectively have extensive executive experience of internationally recognised pharmaceutical, cosmetic and cosmeceutical commercial operations.
We provide a far-sighted, technologically advanced supply chain: from foreign factory to Chinese warehouse and final consumer, DoubleWing controls a consumer-centric, omni-channel system in collaboration with leading third party logistics partners.
Whether via cross-border, e-commerce or general trade, DoubleWing expertly manages the strict regulatory, legal, commercial and logistic hurdles for cosmeceutical products to complete successful market entry.
DoubleWing is launching more than 100 herbal cosmetic and personal care products into the rapidly expanding Chinese market over the next three years. Today’s market for DoubleWing’s herbal products represents about 25% of the total US $40 billion Chinese cosmetic market and is expected to reach US $25 billion by 2023.
Imports of foreign cosmeceuticals into China have grown by 60% over the past three years, led by European, Korean and Japanese companies, reflecting Chinese consumer preference for natural products and concerns over environmental factors affecting the quality of locally produced cosmetics.
DoubleWing Health & Beauty has received EIS Advance Assurance from HMRC.
We are delighted to announce that HMRC has granted DoubleWing Health & Beauty advance assurance for the Enterprise Investment Scheme (EIS).
This venture capital scheme provides UK-based investors with immediate income tax relief, future exemption from capital gains taxes and risk mediation upon
disposal. The EIS is a government-backed, tax-efficient investment scheme.